Jun 29, 2026
17 MIN READ

Navigating Your Path to Wellness: What’s the Starting Dose of Wegovy and Beyond

Most patients begin semaglutide at 0.25 mg weekly, gradually increasing over 16 weeks to reach therapeutic levels. PlexusDx delivers compounded semaglutide injections starting at $149/month, with your dose adjusting based on response—but your price stays flat.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 29, 2026
17 MIN READ

navigating your path to wellness: what’s the starting dose of wegovy and beyond — PlexusDx GLP-1 education

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has transformed weight management by activating GLP-1 receptors that signal fullness and regulate appetite. The FDA-approved Wegovy protocol starts patients at a low dose to minimize side effects, then increases gradually over four months. Understanding how initial dosing works—and what happens after—helps you set realistic expectations for your personalized weight loss journey.

Understanding Semaglutide Starting Dose Protocols

The standard semaglutide initiation follows a step-wise approach designed to help your body adapt safely. Week 1–4 uses 0.25 mg injected once weekly, establishing tolerance while your GLP-1 receptors begin responding. This low starting point reduces nausea and gastrointestinal side effects that can occur when doses escalate too quickly. Clinical trials show that patients who follow this gradual titration are more likely to continue treatment and reach their weight loss goals.

After four weeks, the dose increases to 0.5 mg weekly for another month. By week 9, patients typically move to 1.0 mg weekly, and by week 13, they reach 2.0 mg—the standard maintenance dose used in most weight loss studies. This 16-week ramp-up gives your metabolism time to adjust while allowing your prescriber to monitor how you respond. Some patients find their optimal dose at 1.0 mg, while others need the full 2.0 mg for maximum appetite suppression and metabolic benefit.

How Your Body Responds During the Titration Phase

During the first four weeks, you may notice mild appetite reduction and shifts in food preferences before reaching higher doses. Your brain's satiety centers are beginning to recognize GLP-1 signaling, which triggers feelings of fullness even with smaller meals. Many patients report eating 30–40% fewer calories without deliberate restriction, simply because their hunger signals have recalibrated. This early phase is critical for building confidence that the medication is working, even though you're still at the lowest dose.

Weeks 5–8 bring more noticeable changes as the 0.5 mg dose deepens your body's GLP-1 response. Weight loss typically accelerates during this window, with an average of 2–3 pounds per week in clinical studies. Some people experience temporary nausea or constipation as the dose increases, but these effects usually settle within days as your digestive system adjusts. Your prescriber may pause increases if side effects become uncomfortable, allowing your body more time to adapt before moving to the next tier.

Compounded Semaglutide vs. Branded Wegovy: What PlexusDx Offers

PlexusDx provides semaglutide compounded by licensed 503A pharmacies, delivering the same active ingredient as branded Wegovy at significantly lower cost. Compounded medications are custom-prepared to match your exact dose and schedule, without the markup of mass-market pharmaceutical distribution. Starting at $149 per month flat, PlexusDx eliminates flat per-compound pricing—your medication cost remains stable whether you're at 0.25 mg or 2.0 mg. This transparent pricing model means you never face surprise cost increases as your prescriber optimizes your therapeutic dose.

Both compounded and branded semaglutide undergo the same pharmacokinetic pathway in your body, binding to GLP-1 receptors in your brain, pancreas, and gut. The difference is accessibility: PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorizations. Your dose may need to go up as your body adapts, but your price won't—removing financial barriers to finding your optimal therapeutic level.

Personalizing Your Dose With Genetic Insight

Not everyone responds to semaglutide at the same rate or dose, partly due to genetic variation in GLP-1 receptor sensitivity and metabolic pathways. PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights, including key variants like GLP1R rs6923761 and GIPR rs1800437 that influence how your body processes GLP-1 signals. Patients with certain genetic profiles may reach optimal results at 1.0 mg, while others benefit from advancing to 2.0 mg or combining compounds. Understanding your peptide-pathway genetics helps your prescriber predict which dose tier and formulation will work best for your biology.

The $99 add-on Precision Peptide Genetic Test is available after your first month of treatment, once you've had time to assess initial tolerance. Results map your individual response across 49 peptides, revealing whether you're a strong, moderate, or nuanced responder to GLP-1 therapy. Armed with this data, your provider can confidently adjust your dose strategy, potentially reaching your weight loss plateau faster and with fewer trial-and-error adjustments. This personalized approach transforms weight loss from a one-size-fits-all protocol into a precision medicine experience tailored to your genetic blueprint.

Managing Side Effects During Dose Escalation

Nausea, the most common side effect, typically appears 1–2 hours after injection and resolves within 24 hours. Taking your injection before bedtime may help you sleep through the adjustment period, while eating smaller, lower-fat meals reduces nausea intensity. Constipation occurs because GLP-1 naturally slows gastric emptying—a mechanism that also helps you feel fuller longer. Drinking 2–3 extra liters of water daily, eating fiber-rich vegetables, and gentle movement like walking can ease this transition without delaying your dose increases.

If nausea or other side effects feel severe, inform your PlexusDx provider before your next scheduled increase. Pausing at your current dose for an extra week allows your body to fully acclimate before advancing further. This flexibility is one advantage of compounded therapy: your prescriber can customize your titration timeline to match your tolerance, rather than forcing a rigid four-week schedule. Most side effects diminish dramatically by week 3–4 at each dose level, signaling that your system is adapting and you're ready to progress.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide, and will I stay on it?

Semaglutide begins at 0.25 mg weekly, increasing every four weeks until reaching 2.0 mg—your optimal maintenance dose. Your prescriber may pause or adjust this schedule based on your tolerance and weight loss response. PlexusDx keeps your monthly price flat at $149 as your dose climbs, ensuring cost predictability throughout your treatment journey.

How much weight can I expect to lose in the first month on the starting dose?

At 0.25 mg, most patients lose 0.5–1.5 pounds per week, with noticeable appetite reduction appearing by week 2. Weight loss accelerates as you advance to higher doses; by week 8–12, patients typically see 2–3 pounds weekly. Individual results vary based on baseline metabolism, diet, and activity level—genetic factors also play a role, which the Precision Peptide Genetic Test can reveal.

How much does semaglutide cost with PlexusDx, and is it covered by insurance?

PlexusDx compounded semaglutide starts at $149 per month flat, regardless of your dose level—your price won't increase as you titrate upward. PlexusDx serves all 50 states without requiring insurance, though HSA and FSA accounts can cover the cost. No membership fees or prior authorizations are needed, making treatment accessible and affordable for most patients.

Are there serious side effects I should watch for during dose escalation?

Nausea, constipation, and mild diarrhea are common but usually temporary and manageable with hydration and dietary adjustments. Rare but serious risks include pancreatitis (severe abdominal pain), gallbladder issues, and thyroid concerns—report any persistent pain or unusual symptoms to your provider immediately. Semaglutide is contraindicated in personal or family history of medullary thyroid cancer; your prescriber screens for this before starting treatment.

How does the Precision Peptide Genetic Test help optimize my semaglutide dose?

PlexusDx's $99 genetic test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence how effectively your body responds to GLP-1 therapy. Results predict whether you're likely to reach optimal results at 1.0 mg or need advancing to 2.0 mg, or whether a dual-compound approach like GLP-Squared might work better. This data-driven approach accelerates your path to your target dose with fewer adjustments.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves